Skip to contentC
Cryo Cell International Inc
C
CCELCryo Cell International Inc Q1 2021 · 10-Q
Revenue$6.86M$6.86M−10.0% vs Q1 2020 Net Income$693.59K$693.59K+1.0% vs Q1 2020 EPS Diluted$0.08$0.08±0.0% vs Q1 2020 Operating Income$1,235,261−1.1% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cryo Cell International Inc · CIK 862692 · Engraved from SEC EDGAR
Free Cash Flowderived$2,650,064+1.6% Margins · derivedOperating margin18.0%+1.6 pt vs Q1 2020
Net margin10.1%+1.1 pt vs Q1 2020
ended Feb 28, 2021 · filed Apr 14, 2021 · 45 d after period end